Effects of vaping delta-8-THC on lung health
Respiratory health effects of aerosolized delta-8-THC and its oxidation products
This study is looking at how vaping products with delta-8-THC might affect your lung health, so we can better understand any risks and help keep you safe while using these products.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10954710 on NIH RePORTER |
What this research studies
This research investigates the respiratory health effects of vaping products containing delta-8-tetrahydrocannabinol (delta-8-THC), a psychoactive cannabinoid that has gained popularity since the legalization of cannabidiol (CBD). The study aims to understand how delta-8-THC and its oxidation products affect normal lung cell function, particularly focusing on the potential for these substances to cause lung injury. By examining the biological mechanisms involved, the research seeks to provide critical safety information about vaping delta-8-THC and inform regulatory decisions. Patients may benefit from the findings, which could lead to better understanding and management of vaping-related health risks.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who currently use or have used delta-8-THC vaping products.
Not a fit: Patients who do not use delta-8-THC or other vaping products may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide valuable insights into the safety of vaping delta-8-THC, potentially leading to improved health outcomes for users.
How similar studies have performed: While research on vaping and its health effects is ongoing, this specific investigation into delta-8-THC is relatively novel and has not been extensively studied.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Love, Charlotte Ann — Univ of North Carolina Chapel Hill
- Study coordinator: Love, Charlotte Ann
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.